This test is most useful if any of these apply to you.
If you are moving through menopause, watching your hormone balance, or simply curious about your estrogen, this test offers a way to check one of your key estrogens without a needle. Saliva captures the freely active fraction of the hormone, the part not locked to carrier proteins in your blood.
The honest caveat comes first. Salivary estrone is a research-stage measurement, not a validated clinical test. Its real value is giving you a personal baseline you can watch over time, rather than a single verdict about your health.
Estrone (E1) is one of three main estrogens your body makes. After menopause it becomes the dominant one, because the ovaries slow down and body fat takes over most estrogen production. In blood, the majority of estrone travels bound to proteins, and only the small free portion drifts into saliva.
That free portion is what a saliva test measures. Early physiology work found salivary estrogens sit at only a small fraction of blood levels, commonly reported in the range of about 1 to 8 percent for estrogens generally, so the number reflects the unbound, biologically available hormone. It also means the test operates at very low concentrations, which makes it technically demanding and sensitive to interference.
In postmenopausal women, the single biggest driver of estrone is body fat. Among 4,068 postmenopausal women, average blood estrone was roughly 60 percent higher in those with a BMI over 30 compared with under 25 (30.6 versus 19.1 pg/mL). Fat tissue carries an enzyme that converts other hormones into estrogen, so more fat means more estrone.
This matters because higher long-term estrogen exposure is tied to hormone-driven breast cancer. In one prevention trial, a drug that shuts down that fat-tissue enzyme cut invasive breast cancer incidence by 65 percent versus placebo in healthy postmenopausal women. These findings come from blood estrogen measurements, not saliva, so they inform the biology rather than validate the saliva test directly.
The clearest direct evidence for salivary estrone comes from keratoconus, a condition in which the cornea thins and bulges into a cone shape. Two studies found lower salivary estrone in patients than in healthy controls. The larger one, with 147 patients and 60 controls, saw the reduction hold across sex, age, and disease severity; a smaller study of 64 patients and 14 controls found reduced estrone alongside elevated DHEA-S.
These are associations, not proof of cause. They do not make salivary estrone a diagnostic test for keratoconus, and no study here reports how accurately estrone alone could separate patients from healthy people.
These threads can seem to contradict each other: too much estrone links to breast cancer risk, while too little salivary estrone shows up in keratoconus. Estrone is not a simple good number or bad number marker. It reflects a hormonal state, and different states carry different risks in different tissues. What a given level means depends on your context: your age, sex, body composition, and reproductive stage. That is why a value only becomes interpretable alongside the rest of your picture.
In pregnancy, a related molecule called estrone sulfate rises steadily. Across 106 pregnant women tested weekly, salivary estrone sulfate roughly doubled through the second trimester as a noninvasive window into fetal and placental function. Estrone sulfate is a stored, inactive form rather than estrone itself, so this is a related but different measurement. Researchers who reported it still describe the approach as exploratory and in need of more validation.
Because salivary estrone sits at such low concentrations, a single reading is easily swayed by measurement noise. Levels also differ by sex, running higher in women, and decline modestly with age. That combination makes the trend far more informative than any one snapshot.
No clinical guideline recommends a schedule for serial salivary estrone monitoring, so any retesting rhythm is a personal choice rather than an evidence-based protocol. If you do choose to track it, a baseline now with a repeat when you are changing your weight or lifestyle can show whether your own value is moving. One caveat: most of the evidence on what moves estrone was measured in blood, so a saliva retest may not mirror a blood change exactly. Watching your own saliva trend against your own baseline is the most reliable use of this data.
If your salivary estrone lands far from what you expected, the next move is not to act on the saliva number alone. Confirm it with a standard blood estrogen panel that includes estradiol and estrone, and consider adding FSH and LH to place your reproductive stage in context. An endocrinologist or your primary clinician can help read the combination rather than the single figure.
For postmenopausal women concerned about estrogen and breast cancer risk, this marker is a complement to, not a substitute for, standard screening and a body-composition review. Patterns across several tests carry the weight here; an isolated saliva value does not.
Evidence-backed interventions that affect your Estrone level
Estrone is best interpreted alongside these tests.
Estrone is included in these pre-built panels.